FranchiseVerdict
recoveriX logo
FV-02115·MODERATEStandard67Pre-opening

recoveriX

OtherFranchising since 2023Website
Investment
$72K – $353K
21st pct Other
Avg revenue
—
50th pct Other
Royalty
11.0%
61st pct Other
Units
0
0th pct Other
SBA default
—

Bottom line

  • Total investment $72K – $353K including a $10K franchise fee, 11.0% ongoing royalty.
  • No Item 19 financial performance data disclosed — the franchisor chose not to publish revenue figures.
  • Rated MODERATE with a risk score of 65/100.
  • Auditor disclosed a going-concern note — flagged doubt about the franchisor's ability to continue operations. Verify against the latest FDD.

Item 1 · who you're contracting with

The Franchisor

Legal entity
G.TEC NEUROTECHNOLOGY USA, INC.
Parent company
g.tec medical engineering GmbH
Incorporated in
Delaware
HQ
1580 Columbia Turnpike, Building 2, Suite 1, Castleton-on-Hudson, New York 12033
Auditor
Metwally CPA PLLC
Audited financials
Franchisor revenue
$1.4M
vs $1.4M prior year
⚠ Going-concern note
Disclosed in FDD 2025
Auditor flagged doubt about continued operations. Verify against the latest FDD before deciding.

Yale framework · single-unit ROIC

Returns Analysis

Pulls Item 7 (investment) and Item 19 (revenue) from this brand's FDD into the Yale unlevered-ROIC formula. Override any input to stress-test it against your own assumptions.

The model · Yale framework

What would one recoveriX unit return on the cash you put in?

Revenue · per unit, per year
$
Item 19 not disclosed — typing your own estimate
Franchisor take · royalty + ad fund
Royaltytyp 6–8%
%
Ad fundtyp 3–5%
%
Operating costs · category default: generic
COGS
%
Labor
%
Rent / occupancy
%
Other operating
%
Total invested capital · what you actually put in
Initial investment
$
FDD Item 7: $72K–$353K
Working capital
$
FDD reports $30K–$150K

Unlevered ROIC · per unit

22%

Below typical band (30–60%)

0%30–60% Yale band80%
Store EBITDA · annual
$68K
EBITDA margin
9.0%
Total invested
$302K
Payback
54 mo
Unit-level only. A multi-unit portfolio gives up roughly 5–15% of this to shared services (corporate G&A) before reaching the ~10-unit break-even Yale describes.

Overview

About

recoveriX franchisees operate rehabilitation/recovery therapy clinics, likely specializing in technology-assisted or specialized recovery protocols. Day-to-day operations involve patient/client treatment delivery, equipment management, clinical staff supervision, insurance billing, and marketing to build local client bases in protected territories.

CEO
Christoph Guger
Founded
2014
FDD year
2025
States available
0

Item 7 · what it costs

The Vitals

Total investment
$72K – $353K
All-in to open one unit
Liquid capital
$30K – $150K
Cash you must have on hand
Franchise fee
$10K
Royalty
11.0%
Percentage of Gross Sales · typical 6–8%
Ad fund
Up to $500 per month
Total fee load
11.0%
vs 9–13% typical

Item 19

Financial Performance

This franchisor did not disclose financial performance representations in Item 19, or our extractor could not parse them.

Item 20 · unit dynamics

The Growth Chart

Total units
0
Opened
0
Last reporting year
Closed
0
Company-owned
0
Corporate units in the system
Multi-unit owners
66.7%
2023
0±0
Franchised units
2024
0
Franchised units
2025
0
Franchised units

Year-over-year franchised unit counts and net change. Source: FDD Item 20.

Government records

SBA Loan Data

Aggregated from SBA 7(a) loan disclosures, public data unique to FranchiseVerdict.

No SBA loan data available for this brand.

FranchiseVerdict rating + FDD Items 3, 5, 6, 12, 17

Risk & Legal

65
Risk · 0-100
MODERATE65 / 100

recoveriX presents elevated risk due to complete absence of operating unit data, undisclosed financial performance metrics, and a going concern status in a pre-revenue franchise system with above-market royalties.

Score breakdown · what drove the 65 / 100 rating

  1. 01MEDZero disclosed franchise units with unknown growth trajectory indicates either brand-new system or undisclosed contraction
  2. 02MEDNo average revenue or net income disclosure (missing Item 19) prevents ROI validation against $72K-$352.5K investment range
  3. 03MINOR11% royalty rate is above-market for wellness/therapy franchises, reducing margins without proven unit economics
  4. 04MINORWide investment range ($280.5K spread) suggests inconsistent startup costs or undefined territory/build-out standards
  5. 05HIGHGoing Concern status with zero operating units raises sustainability and franchisor financial stability questions
  6. 06MINOR5-year term is shorter than industry standard (10 years), indicating higher renewal/renegotiation risk

Severity inferred from the FDD text · not a regulatory classification

FDD Items 5, 6, 12, 17 · continued from Risk & Legal

Contract & Territory Detail

Territory
Radius and Population
Protected territory
Yes
Initial term
5 years
Renewal term
5 years
Online sales rights
Restricted
Franchisor can compete
Yes
Hire a manager?
Allowed
Litigation count
0
Right of first refusal
Yes
Franchisor can buy back on resale
Mandatory arbitration
Yes
Jury trial waiver
Yes
Non-compete
2 yrs
Post-termination restriction
Owner-operator
Optional
Governing law
New York

Item 11

Training & Operations

Classroom training
14 hrs
On-the-job training
10 hrs

Item 20

Franchisee Contacts

Phone numbers extracted directly from this brand's FDD Item 20. After purchase, you'll also receive a list of validation questions tailored to this brand.

No franchisee contacts available for recoveriX. This brand's FDD Item 20 did not include a contactable franchisee list.

FDD download

recoveriX · FDD (2025) PDF

Single-page checkout · instant download · CSV export of contacts available separately above